Mkts

Foghorn Therapeutics Inc.

NASDAQ: FHTX
$2.07+0.20 (+10.70%)
As of Nov 9, 9:30 AM ET

Key statistics

Day range
1.912.13
52-week range
1.797.61
Today
Open2.02
Previous close2.07
Volume122.4K
Valuation
Market cap111.05M
P/E ratio—
EPS (TTM)-0.98
Income & risk
Dividend / yield—
Beta2.94
Avg volume642.5K
Discussion

FHTX News

Stories mentioning FHTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue3,2679,2478,1537,5575,9522,8567,8086,888
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development18,25922,04620,00221,79221,62620,50824,68923,797
Sales General & Admin
Total Operating Expenses24,84033,12526,65428,65428,86526,86131,66033,520
Operating Income (Loss)(21,573)(23,878)(18,501)(21,097)(22,913)(24,005)(23,852)(26,632)
Interest Income
Interest Expense
Other Expense
Pretax Income(19,503)(19,122)(22,979)
Tax Provision0.000.000.00
Net Income (Loss)(19,875)(21,664)(15,849)(17,936)(18,834)(19,503)(19,122)(22,979)
Earnings Per Share (Basic)(0.29)(0.34)(0.25)(0.28)(0.30)(0.36)(0.31)(0.45)
Earnings Per Share (Diluted)(0.29)(0.34)(0.25)(0.28)(0.30)(0.36)(0.31)(0.45)
Weighted Average Shares Outstanding (Basic)69,54062,98163,02962,97862,84954,89962,60351,580
Weighted Average Shares Outstanding (Diluted)69,54062,98163,02962,97862,84954,89962,60351,580

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About FHTX

Foghorn Therapeutics Inc. (NASDAQ: FHTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol FHTX. It last traded at $2.07 (Nov 9, 2026, 9:30 AM ET), up 10.7% on the day. That gives Foghorn Therapeutics a market capitalisation of $111.1M.

Over the past 52 weeks FHTX has traded between $1.79 and $7.61.

Revenue for the quarter ended Mar 31, 2026 was $3.3M; a net loss of $19.9M. Revenue was down 45.1% from $6.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$3.3M-$19.9M-608.4%
Dec 31, 2025$9.2M-$21.7M-234.3%
Sep 30, 2025$8.2M-$15.8M-194.4%
Jun 30, 2025$7.6M-$17.9M-237.3%

From Foghorn Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…